Lannett Comes Out Firing On Insulin Pipeline Prospects

US-Based Player Needs Big Launches To Reverse Depleted P&L Trend

Eyes US flag
Lannett is eyeing a number of key US launches • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products